TIRmed Pharma receives SME Instrument Phase 1 grant from EU Grant No 885787-TIR-C


In Dec, 2019 TIRmed Pharma was awarded funding from the European Union´s Horizon 2020 research and innovation progamme under grant agreement number 885787-TIR-C regarding the development of a cream to treat immune responses in atopic dermatitis.